NIH director discusses the $1,000 genome, basic science

02/16/2012 | Medscape (free registration)

Advances in genome sequencing, genomic editing and induced pluripotent stem cells will revolutionize the practice of medicine, NIH Director Francis Collins says in this in-depth interview. For example, iPS cells could be used not only to study a particular patient's disease but also to develop personalized treatments, he says. Basic science supported by the NIH will help scientists develop algorithms to analyze complicated DNA and RNA sequences and translate the information into therapies, he says.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
Springfield, OR
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA